Answer
In the absence of compatibility studies, Keytruda (pembrolizumab) 25 mg/mL concentrate for solution for infusion must not be mixed with other medicinal products except those mentioned in section 6.6.
Sources for this answer
- KEYTRUDA 25 mg/mL concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §6.2 Incompatibilities · Version 67Document updated
Sources checked